Savara Inc Goodwill, Period Increase (Decrease)
Savara Inc (SVRA) reported Goodwill, Period Increase (Decrease) of $0 for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Notes › Goodwill and Other
us-gaap:GoodwillPeriodIncreaseDecrease · last filed 2019-11-07
- Savara Inc goodwill, period increase (decrease) for the quarter ending 2019-03-31 was -$100.00K.
| Period end | Goodwill, Period Increase (Decrease) 3 month | Goodwill, Period Increase (Decrease) 9 month |
|---|---|---|
| 2019-09-30 | $0.00 10-Q · filed 2019-11-07 | |
| 2019-03-31 | -$100.00K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |